Navid Biotech logo — Navid Biotech is a biotech firm that focuses on the R&D of s...

Navid Biotech

Navid Biotech is a biotech firm that focuses on the R&D of simple and visual new nucleic acid detection technology.

Founded 2016 Seed Total: $10.29M Biopharma, Biotechnology +1

General Information

Company Name Navid Biotech
Founded Year 2016
Industries Biopharma, Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Navid Biotech. To contact Navid Biotech, visit naidesw.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Navid Biotech compare?

A PDF of Navid Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Navid Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Navid Biotech

Navid Biotech is a biotech firm that focuses on the R&D of simple and visual new nucleic acid detection technology. Founded in 2016, this company operates in the Biopharma, Biotechnology, and Health Care industries. In their latest funding round on 01 January 2022, they raised CNY10.00M in a Seed Round investment, with participation from notable investors including Milestone Capital and Qingdao Hi-Tech Venture Capital. With a clear mission and strong financial backing, Navid Biotech presents an exciting opportunity for investors seeking to support innovative advancements in biotech and healthcare. This pioneering firm's focus on nucleic acid detection technology signifies its potential to make significant contributions to the industry, making it a compelling prospect for venture capital investment.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round CNY10.00M 2
Milestone Capital, Qingdao Hi-Tech Venture Capital
01 Jan 2022
Angel Round $290.00K 1
Milestone Capital China
15 Aug 2018

Navid Biotech Alternatives & Competitors

View All Alternatives
Navid Biotech vs

Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation detection in...

Seed
18 employees
Biotechnology, Health Care
Navid Biotech vs
Vymedic, Inc.
Vymedic, Inc. United States

Vymedic, Inc. is a biotech company and a leader in Amino Acid metabolic technology.

Seed
2 employees
Biotechnology, Health Care
Navid Biotech vs
HebeCell Corp
HebeCell Corp United States

HebeCell is a Natick, MA based biotech company that focuses on immuno-oncology and regenerative medi...

Series A
11 employees
Biotechnology, Health Care

FAQ About Navid Biotech

Navid Biotech is a biotech firm that focuses on the R&D of simple and visual new nucleic acid detection technology.
Navid Biotech was founded in 2016.
Navid Biotech operates in Biopharma, Biotechnology and Health Care.
Navid Biotech has completed 2 funding rounds, raising a total of $10.29M. The latest funding stage is Seed.
Top alternatives and competitors to Navid Biotech include Rarity Bioscience , Vymedic, Inc., HebeCell Corp, Haoma Medica Ltd., MediMabBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Navid Biotech and Rarity Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Navid Biotech, https://bouncewatch.com/company/navid-biotech, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes